HSPG2 and rheumatoid arthritis: The normalization of plasma levels of HS/H in women with RA suggests that early, aggressive treatment of RA aimed at suppressing the inflammatory response contributes to an improvement in the balance between the synthesis, secretion, modification and degradation of HSPG/HS at the cell surface, thereby reducing endothelial dysfunction.